Drug combo before surgery aims to save men's sexual function
NCT ID NCT02949284
Summary
This study is testing whether giving hormone-blocking drugs for three months before prostate cancer surgery helps surgeons better preserve the nerves needed for sexual function. Men with high-risk prostate cancer are randomly assigned to receive either one drug, a combination of drugs, or no drugs before their operation. The main goal is to see if these pre-surgery treatments improve the chances of maintaining potency after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE II PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
Yale Cancer Center
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.